Meg Croucher is the CEO of WARPNINE, a Western Australia–based charity accelerating access to innovative clinical trials and translational research for pancreatic, gastro-intestinal and rare cancers. Through a strong focus on collaboration and patient-centred impact, she is committed to bridging the gap between research and real-world care—ensuring promising discoveries reach patients sooner.